Display options
Share it on

Mol Neurodegener. 2007 Jul 09;2:14. doi: 10.1186/1750-1326-2-14.

ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity.

Molecular neurodegeneration

Rodrigo A Fuentealba, Maria Ines Barría, Jiyeon Lee, Judy Cam, Claudia Araya, Claudia A Escudero, Nibaldo C Inestrosa, Francisca C Bronfman, Guojun Bu, Maria-Paz Marzolo

Affiliations

  1. FONDAP Center for Cell Regulation and Pathology (CRCP), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile. [email protected]

PMID: 17620134 PMCID: PMC1939850 DOI: 10.1186/1750-1326-2-14

Abstract

BACKGROUND: The generation of the amyloid-beta peptide (Abeta) through the proteolytic processing of the amyloid precursor protein (APP) is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies highlight APP endocytosis and localization to lipid rafts as important events favoring amyloidogenic processing. However, the precise mechanisms underlying these events are poorly understood. ApoER2 is a member of the low density lipoprotein receptor (LDL-R) family exhibiting slow endocytosis rate and a significant association with lipid rafts. Despite the important neurophysiological roles described for ApoER2, little is known regarding how ApoER2 regulates APP trafficking and processing.

RESULTS: Here, we demonstrate that ApoER2 physically interacts and co-localizes with APP. Remarkably, we found that ApoER2 increases cell surface APP levels and APP association with lipid rafts. The increase of cell surface APP requires the presence of ApoER2 cytoplasmic domain and is a result of decreased APP internalization rate. Unexpectedly, ApoER2 expression correlated with a significant increase in Abeta production and reduced levels of APP-CTFs. The increased Abeta production was dependent on the integrity of the NPxY endocytosis motif of ApoER2. We also found that expression of ApoER2 increased APP association with lipid rafts and increased gamma-secretase activity, both of which might contribute to increased Abeta production.

CONCLUSION: These findings show that ApoER2 negatively affects APP internalization. However, ApoER2 expression stimulates Abeta production by shifting the proportion of APP from the non-rafts to the raft membrane domains, thereby promoting beta-secretase and gamma-secretase mediated amyloidogenic processing and also by incrementing the activity of gamma-secretase.

References

  1. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13461-6 - PubMed
  2. Mol Cell Biol. 2005 Nov;25(21):9259-68 - PubMed
  3. Nat Cell Biol. 2005 Nov;7(11):1118-23 - PubMed
  4. Mech Ageing Dev. 2006 Feb;127(2):138-47 - PubMed
  5. J Neurosci. 2006 Jan 11;26(2):418-28 - PubMed
  6. Neurology. 2006 Jan 24;66(2 Suppl 1):S69-73 - PubMed
  7. Biochemistry. 2006 Feb 28;45(8):2618-28 - PubMed
  8. Traffic. 2006 Apr;7(4):408-15 - PubMed
  9. Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5161-6 - PubMed
  10. Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5573-8 - PubMed
  11. J Biol Chem. 2006 Aug 25;281(34):24521-30 - PubMed
  12. FEBS Lett. 2006 Oct 9;580(23):5525-32 - PubMed
  13. J Biol Chem. 2006 Nov 24;281(47):36180-6 - PubMed
  14. Nat Med. 2006 Dec;12(12):1390-6 - PubMed
  15. Ann N Y Acad Sci. 2006 Nov;1086:35-53 - PubMed
  16. J Biol Chem. 2007 Mar 9;282(10):7606-15 - PubMed
  17. Arch Biochem Biophys. 1990 Sep;281(2):251-6 - PubMed
  18. Proc Natl Acad Sci U S A. 1979 Jan;76(1):514-7 - PubMed
  19. J Biol Chem. 1983 Apr 25;258(8):4715-24 - PubMed
  20. Anal Biochem. 1984 Apr;138(1):141-3 - PubMed
  21. Neurodegeneration. 1995 Mar;4(1):23-32 - PubMed
  22. J Biol Chem. 1994 Jul 1;269(26):17386-9 - PubMed
  23. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649-53 - PubMed
  24. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81 - PubMed
  25. Brain Res. 1977 May 13;126(3):397-42 - PubMed
  26. J Biol Chem. 1996 Apr 5;271(14):8373-80 - PubMed
  27. J Cell Sci. 1996 May;109 ( Pt 5):991-8 - PubMed
  28. J Cell Sci. 1996 May;109 ( Pt 5):999-1008 - PubMed
  29. J Biol Chem. 1997 Mar 28;272(13):8498-504 - PubMed
  30. Genomics. 1997 Jun 1;42(2):185-91 - PubMed
  31. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53 - PubMed
  32. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6460-4 - PubMed
  33. J Biol Chem. 1999 Jan 8;274(2):1164-71 - PubMed
  34. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3922-7 - PubMed
  35. Neuroscience. 1999 Mar;90(3):903-11 - PubMed
  36. Eur J Biochem. 1999 May;262(1):230-9 - PubMed
  37. Cell. 1999 Jun 11;97(6):689-701 - PubMed
  38. J Biol Chem. 1999 Jul 2;274(27):18851-6 - PubMed
  39. Neuron. 1999 Oct;24(2):471-9 - PubMed
  40. Neuron. 1999 Oct;24(2):481-9 - PubMed
  41. J Biol Chem. 2000 Mar 10;275(10):7410-5 - PubMed
  42. J Biol Chem. 2000 Jun 2;275(22):17187-94 - PubMed
  43. J Biol Chem. 2000 Aug 18;275(33):25616-24 - PubMed
  44. J Biol Chem. 2000 Aug 18;275(33):25625-32 - PubMed
  45. J Biol Chem. 2000 Oct 27;275(43):33729-37 - PubMed
  46. J Biol Chem. 2000 Nov 24;275(47):36794-802 - PubMed
  47. Arch Neurol. 2000 Oct;57(10):1439-43 - PubMed
  48. Lancet. 2000 Nov 11;356(9242):1627-31 - PubMed
  49. J Neurochem. 2001 Jan;76(1):173-81 - PubMed
  50. Physiol Rev. 2001 Apr;81(2):741-66 - PubMed
  51. J Biol Chem. 2001 Jun 22;276(25):22160-9 - PubMed
  52. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5856-61 - PubMed
  53. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5815-20 - PubMed
  54. Curr Biol. 2001 Aug 21;11(16):1288-93 - PubMed
  55. Neurobiol Dis. 2001 Oct;8(5):890-9 - PubMed
  56. Neuron. 2001 Nov 20;32(4):579-89 - PubMed
  57. Neurosci Lett. 2001 Dec 28;316(3):145-8 - PubMed
  58. Annu Rev Cell Dev Biol. 2002;18:25-51 - PubMed
  59. J Cell Biol. 2002 Aug 5;158(3):551-61 - PubMed
  60. J Biol Chem. 2002 Oct 18;277(42):39944-52 - PubMed
  61. EMBO J. 2002 Nov 1;21(21):5691-700 - PubMed
  62. J Cell Biol. 2003 Jan 6;160(1):113-23 - PubMed
  63. J Biol Chem. 2003 Jul 4;278(27):24277-84 - PubMed
  64. Traffic. 2003 May;4(5):291-301 - PubMed
  65. J Cell Sci. 2003 Aug 15;116(Pt 16):3339-46 - PubMed
  66. Traffic. 2003 Aug;4(8):553-65 - PubMed
  67. J Biol Chem. 2003 Sep 26;278(39):37386-92 - PubMed
  68. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11735-40 - PubMed
  69. J Biol Chem. 2003 Dec 19;278(51):51035-43 - PubMed
  70. Neuron. 2004 Jan 8;41(1):7-10 - PubMed
  71. Mol Biol Cell. 2004 Jul;15(7):3433-49 - PubMed
  72. J Biol Chem. 2004 Jul 9;279(28):29639-46 - PubMed
  73. J Biol Chem. 2004 Aug 13;279(33):34302-10 - PubMed
  74. J Biol Chem. 2004 Oct 22;279(43):44945-54 - PubMed
  75. Neurosci Lett. 2004 Sep 23;368(2):144-7 - PubMed
  76. J Neurosci. 2004 Nov 10;24(45):10191-200 - PubMed
  77. J Biol Chem. 2005 Mar 25;280(12):11696-703 - PubMed
  78. J Biol Chem. 2005 Apr 15;280(15):15464-70 - PubMed
  79. J Biol Chem. 2005 May 6;280(18):17777-85 - PubMed
  80. J Cell Sci. 2005 Mar 15;118(Pt 6):1099-102 - PubMed
  81. J Biol Chem. 2005 Jul 8;280(27):25892-900 - PubMed
  82. Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):31-9 - PubMed
  83. J Neurosci. 2005 Jun 29;25(26):6127-36 - PubMed
  84. Neuron. 2005 Jul 21;47(2):191-9 - PubMed
  85. BMC Cell Biol. 2005;6:30 - PubMed
  86. Traffic. 2005 Sep;6(9):820-38 - PubMed
  87. Neuron. 2005 Aug 18;47(4):567-79 - PubMed

Publication Types

Grant support